Changing Role of Agencies? In house v/s Outsourcing.

A few years ago, creating a marketing campaign involved a familiar sequence.
The client developed a brief. The agency conducted brainstorming sessions. Creative routes were explored. Designs were developed. Assets were adapted. Approvals followed. Timelines stretched into weeks.

Today, Artificial Intelligence is fundamentally changing this workflow.
A marketer can generate twenty campaign concepts before lunch. Create visual references in minutes. Develop multiple headline options instantly. Generate videos, presentations, animations, and social media adaptations at a fraction of historical costs.

This naturally raises a question: If AI can do so much, do organizations still need agencies?The answer is yes. But not for the same reasons as before.
Historically, agencies created value through a combination of strategy, creativity, execution, and production.

AI is rapidly automating large parts of production.

Asset resizing. Visual adaptation. Copy variations. Storyboards. Video edits. A/B testing variants. Many tasks that once consumed days can now be completed in hours.

This means pharmaceutical companies may increasingly choose to perform some activities internally: First drafts of visual aids. Initial campaign concepts. Alternative taglines. Training material adaptation. Content personalization. Social media asset generation

These activities can now be executed faster and more economically by in-house teams equipped with AI tools.

The future agency may spend less time producing assets and more time helping clients answer difficult questions:

• What customer insight matters most, especially in the context of communication design that could shape customer behaviours ?
• What unmet need (s) should we address among multiple needs provided by data analytics ?
• What brand position should we own ?
• What emotional tension should we leverage ?
• How should the brand evolve over time ?

AI can generate hundreds of ideas. It cannot easily determine which idea should become the brand’s long-term idea / communication theme.
AI can create content. Humans still decide what is worth saying.
AI can accelerate creativity. Humans still provide judgement.

For pharmaceutical companies, this shift may redefine client-agency relationships. The winners will not be those who use the most AI. They will be those who redesign their workflows, roles, and partnerships around it.